Literature DB >> 4728069

Preclinical toxicology studies with tobramycin.

J S Welles, J L Emmerson, W R Gibson, R Nickander, N V Owen, R C Anderson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4728069     DOI： 10.1016/0041-008x(73)90313-x

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN： 0041-008X            Impact factor:   4.219


× No keyword cloud information.
  6 in total

1.  Tobramycin nephrotoxicity. A prospective clinical study.

Authors:  A Coca; J Blade; A Martinez; F Segura; E Soriano; M Ribas-Mundo
Journal:  Postgrad Med J       Date:  1979-11       Impact factor: 2.401

2.  Effect of cefamandole nafate on the toxicity of tobramycin.

Authors:  J S Wold; S A Turnipseed; W D Broddle; N V Owen
Journal:  Antimicrob Agents Chemother       Date:  1977-10       Impact factor: 5.191

3.  Atracurium and vecuronium interaction with gentamicin and tobramycin.

Authors:  J Y Dupuis; R Martin; J P Tétrault
Journal:  Can J Anaesth       Date:  1989-07       Impact factor: 5.063

4.  Gentamicin and tobramycin nephrotoxicity. A morphologic and functional comparison in the rat.

Authors:  D C Houghton; C E Plamp; J M DeFehr; W M Bennett; G Porter; D Gilbert
Journal:  Am J Pathol       Date:  1978-10       Impact factor: 4.307

Review 5.  Tobramycin: a review of its antibacterial and pharmacokinetic properties and therapeutic use.

Authors:  R N Brogden; R M Pinder; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

6.  Comparative low-dose nephrotoxicities of gentamicin, tobramycin, and amikacin.

Authors:  G H Hottendorf; L L Gordon
Journal:  Antimicrob Agents Chemother       Date:  1980-07       Impact factor: 5.191
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.